Skip to main content
Yanjiu Conference logo

Call for Papers – ICAOCD 2027, Taipei

International Conference on AI-Assisted Oncology and Cancer Diagnostics — ICAOCD 2027

Dates

28–29 March 2027

Venue

Taipei, Taiwan

Field

AI-Assisted Oncology and Cancer Diagnostics

Topics of ICAOCD 2027

Original papers are invited in AI-Assisted Oncology and Cancer Diagnostics. Submit by 24 February 2027.

Submit Your Paper

Topics include, but are not limited to:

AI Applications in Cancer Diagnosis

  • Machine learning algorithms for early detection
  • Image analysis in radiology and pathology
  • AI-driven predictive models for treatment outcomes

Data Privacy and Ethical Considerations

  • Patient consent in AI data usage
  • Bias in AI algorithms affecting outcomes
  • Regulatory challenges for AI applications

Integration of AI in Clinical Workflow

  • AI tools in decision support systems
  • Impact on radiologists' workflow and efficiency
  • Training healthcare professionals on AI systems

AI and Personalized Medicine

  • Tailoring treatment plans using AI insights
  • Genomic data analysis for precision oncology
  • Real-world evidence from AI in clinical trials

Challenges in AI Implementation

  • Technical barriers to widespread AI adoption
  • Interdisciplinary collaboration requirements
  • Maintaining AI systems over time

Future Directions in AI Research

  • Emerging technologies in oncology
  • Longitudinal studies for AI impact
  • Global collaborations for shared data resources

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICAOCD 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Taipei This March

Present your research, meet peers from over 50 countries and help shape the future of AI-Assisted Oncology and Cancer Diagnostics.